Treatment of cancer using combination therapies comprising GDC-6036 and GDC-0077
US12383557B2 · kind B2 · utility
0Cited by
3References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 4, 2023 |
| Grant date | Aug 12, 2025 |
| Priority date | — |
| Expiry date | Jul 17, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are combination therapies comprising GDC-6036 and inavolisib and methods of using the same to treat cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.